$54.48
−3.64%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$56.38
From 52W high−15.85%
Volume1.01M
Market cap$8.30B
P/E (TTM)—
P/S (TTM)2.4x
Div yield0.37%
Key dataOct 16, 2026
Open
$56.38
From 52W high
−15.85%
Volume
1.01M
Market cap
$8.30B
ValuationView details →
P/E (Fwd)
22.8x
EV/EBITDA
40.6x
P/E (TTM)
—
RSI (14)
39.3
MomentumView details →
1D Return
−3.64%
YTD Return
+16.84%
SummaryUpdated Jun 1, 2026
Bruker Corporation (NASDAQ:BRKR) is a leading developer, manufacturer, and distributor of scientific instruments and analytical solutions founded in 1991 and headquartered in Billerica, Massachusetts. The company went public in 2000 and has grown through strategic acquisitions and organic expansion to become a major player in the life sciences, materials research, and industrial analysis markets. Bruker serves customers globally across academic research institutions, pharmaceutical companies, biotechnology firms, government laboratories, and industrial manufacturers with sophisticated analytical instruments that enable scientific discovery and quality control processes.
Similar companies
Latest newsMore news →
Bank of America Corp DE reduced its stake in Bruker Corporation by 3.2% during the quarter, selling 30,371 shares, according to a Form 13F filing.63d agoBruker Corp reported Q2 2026 total revenue of $838.5 million, a 5.2% increase year-over-year, with a GAAP diluted loss per share of $0.41 and non-GAAP diluted EPS of $0.49, and provided FY2026 guidance for organic revenue growth of 1-2% and non-GAAP EPS of $2.10-$2.15.74d ago